Pompili, Maurizio
 Distribuzione geografica
Continente #
EU - Europa 8.642
NA - Nord America 7.336
AS - Asia 3.017
SA - Sud America 75
AF - Africa 48
Continente sconosciuto - Info sul continente non disponibili 26
OC - Oceania 17
Totale 19.161
Nazione #
US - Stati Uniti d'America 7.269
DE - Germania 3.259
SE - Svezia 1.650
CN - Cina 1.360
IT - Italia 929
SG - Singapore 839
UA - Ucraina 717
IE - Irlanda 508
FR - Francia 352
ID - Indonesia 299
GB - Regno Unito 285
FI - Finlandia 263
RU - Federazione Russa 212
TR - Turchia 177
PL - Polonia 154
IN - India 133
BE - Belgio 69
CA - Canada 48
BR - Brasile 46
NL - Olanda 40
JP - Giappone 39
IR - Iran 37
CI - Costa d'Avorio 33
CZ - Repubblica Ceca 33
AT - Austria 31
HK - Hong Kong 30
RO - Romania 22
CH - Svizzera 21
EU - Europa 21
ES - Italia 20
VN - Vietnam 17
AU - Australia 15
GR - Grecia 12
IL - Israele 12
LT - Lituania 11
TW - Taiwan 11
PT - Portogallo 10
AE - Emirati Arabi Uniti 9
HU - Ungheria 9
KG - Kirghizistan 9
BZ - Belize 7
CL - Cile 7
EC - Ecuador 7
DK - Danimarca 5
KR - Corea 5
PA - Panama 5
PE - Perù 5
TZ - Tanzania 5
A2 - ???statistics.table.value.countryCode.A2??? 4
AR - Argentina 4
LK - Sri Lanka 4
MD - Moldavia 4
MX - Messico 4
AL - Albania 3
BD - Bangladesh 3
EG - Egitto 3
IQ - Iraq 3
MK - Macedonia 3
MY - Malesia 3
NO - Norvegia 3
SY - Repubblica araba siriana 3
TH - Thailandia 3
UZ - Uzbekistan 3
AZ - Azerbaigian 2
BG - Bulgaria 2
BY - Bielorussia 2
CO - Colombia 2
EE - Estonia 2
HR - Croazia 2
KH - Cambogia 2
KW - Kuwait 2
KZ - Kazakistan 2
LV - Lettonia 2
MA - Marocco 2
NZ - Nuova Zelanda 2
PH - Filippine 2
PK - Pakistan 2
RE - Reunion 2
SA - Arabia Saudita 2
SC - Seychelles 2
SK - Slovacchia (Repubblica Slovacca) 2
UY - Uruguay 2
VA - Santa Sede (Città del Vaticano) 2
VE - Venezuela 2
A1 - Anonimo 1
AM - Armenia 1
CR - Costa Rica 1
CY - Cipro 1
GE - Georgia 1
IM - Isola di Man 1
IS - Islanda 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
NI - Nicaragua 1
PR - Porto Rico 1
TN - Tunisia 1
Totale 19.161
Città #
Chandler 1.553
Singapore 640
Ashburn 600
Dublin 503
Jacksonville 415
San Mateo 328
Nanjing 307
Jakarta 294
New York 248
Ann Arbor 234
Wilmington 209
Nürnberg 207
Boston 205
Princeton 175
Milan 168
Rome 161
Dearborn 158
Izmir 155
Moscow 152
Marseille 138
Cattolica 136
Woodbridge 123
Warsaw 113
Helsinki 109
Houston 108
Nanchang 108
Los Angeles 105
Chicago 100
Beijing 99
Seattle 93
Munich 89
Boardman 88
Bremen 84
Redwood City 84
Fairfield 82
Brussels 69
Shenyang 67
Zhengzhou 67
Lancaster 63
Kunming 57
Lawrence 56
Hebei 53
Changsha 49
Hangzhou 49
Norwalk 48
Tianjin 43
Guangzhou 42
University Park 42
Mountain View 40
Redmond 40
Pune 39
Kraków 37
Augusta 34
Abidjan 33
Jiaxing 31
Jinan 31
San Jose 31
London 28
Shanghai 28
Falkenstein 27
Leawood 27
Nuremberg 24
Toronto 24
Cambridge 23
Vienna 23
Hong Kong 22
Paris 21
San Diego 21
Frankfurt am Main 20
Fremont 20
Brno 19
Detroit 18
Washington 18
Hefei 17
Santa Clara 17
Kish 16
Madrid 16
Andover 15
Bologna 14
Amsterdam 13
Lanzhou 13
Ottawa 13
Taizhou 13
Auburn Hills 12
Simi Valley 12
Zurich 12
Changchun 11
Edinburgh 11
Ningbo 11
Phoenix 11
Tokyo 11
Florence 10
Hanoi 10
Lappeenranta 10
Las Vegas 10
San Francisco 10
Bishkek 9
Columbus 9
Falls Church 9
Hounslow 9
Totale 10.079
Nome #
Differentiating hepatocellular carcinoma from dysplastic nodules at gadobenate dimeglumine-enhanced hepatobiliary-phase magnetic resonance imaging 396
Posttransplant lymphoproliferative disorders after liver transplantation: analysis of early and late cases in a 255 patient series 298
Chemotherapy for Hepatocellular Carcinoma: Current Evidence and Future Perspectives. 260
Enhancement patterns of intrahepatic mass-forming cholangiocarcinoma at multiphasic computed tomography and magnetic resonance imaging and correlation with clinicopathologic features 212
A phase II study of sunitinib in advanced hepatocellular carcinoma 209
Single-step multimodal locoregional treatment for unresectable hepatocellular carcinoma: balloon-occluded percutaneous radiofrequency thermal ablation (BO-RFA) plus transcatheter arterial chemoembolization (TACE) 186
Long term effectiveness of resection and radiofrequency ablation for single hepatocellular carcinoma <= 3 cm. Results of a multicenter Italian survey. 184
Non-alcoholic fatty liver disease is associated with high prevalence of gastro-oesophageal reflux symptoms 162
Complete Metabolic Response with Recanalization of Portal Vein Tumor Thrombosis after Sunitinib in a Patient with Advanced Hepatocellular Carcinoma 160
Prevalence, characteristics and severity of non-alcoholic fatty liver disease in patients with chronic plaque psoriasis 160
Role of diffusion-weighted imaging, apparent diffusion coefficient and correlation with hepatobiliary phase findings in the differentiation of hepatocellular carcinoma from dysplastic nodules in cirrhotic liver 155
Single-step multimodal locoregional treatment for unresectable hepatocellular carcinoma: balloon-occluded percutaneous radiofrequency thermal ablation (BO-RFA) plus transcatheter arterial chemoembolization (TACE) 154
Severe veno-occlusive disease after autologous peripheral blood stem cell transplantation for high-grade non-Hodgkin lymphoma: report of a successfully managed case and a literature review of veno-occlusive disease. 150
Prospective study of hepatitis B virus reactivation in patients with hematological malignancies 149
HepPar1-Positive Circulating Microparticles Are Increased in Subjects with Hepatocellular Carcinoma and Predict Early Recurrence after Liver Resection 148
Non-alcoholic fatty liver disease is associated with high prevalence of gastro-oesophageal reflux symptoms 147
Early prediction of response to sorafenib in patients with advanced hepatocellular carcinoma: the role of dynamic contrast enhanced ultrasound 146
Radiofrequency ablation plus drug-eluting beads transcatheter arterial chemoembolization for the treatment of single large hepatocellular carcinoma 141
Ethanol injection is highly effective for hepatocellular carcinoma smaller than 2 cm 136
Effect of rifaximin on gut microbiota composition in advanced liver disease and its complications 136
Thrombotic risk factors in patients with liver cirrhosis: correlation with MELD scoring system and portal vein thrombosis development 133
Contrast-enhanced ultrasound assessment of arterial vascularization of small nodules arising in the cirrhotic liver 129
recurrent acute hepatitis associated with use of cetrizine 127
Early prediction of response to Sorafenib in patients with advanced hepatocellular carcinoma: the role of dynamic contrast enhanced ultrasound 126
A case of non-occlusive mesenteric ischemia and hepatic portal venous gas: not everyone knows that… 125
The Effect of CYP, GST, and SULT Polymorphisms and Their Interaction with Smoking on the Risk of Hepatocellular Carcinoma 125
A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19 124
Botulinum toxin A versus B in sialorrhea: A prospective, randomized, double-blind, crossover pilot study in patients with amyotrophic lateral sclerosis or Parkinson's disease. 123
Hepatocellular carcinoma treated by conventional transarterial chemoembolization in field-practice: serum sodium predicts survival 117
Hepatocellular carcinoma recurrence in patients with curative resection or ablation: impact of HCV eradication does not depend on the use of interferon 117
Treatment of recurrent genotype 4 hepatitis C after liver transplantation: early virological response is predictive of sustained virological response. An AISF RECOLT-C group study 116
New signs and old applications of echo-color-Doppler should always be comapred to a gold-standard 111
Transarterial chemoembolization with degradable starch microspheres (DSM-TACE): an alternative option for advanced HCC patients? Preliminary results 109
[The treatment of hepatocellular carcinoma: an update] 108
revalence, characteristics and management of occult hepatitis B virus infection in patients with chronic lymphocytic leukemia: a single center experience. 107
The Role of Antibiotics in Gut Microbiota Modulation: The Eubiotic Effects of Rifaximin 106
Long-term metformin treatment is able to reduce the prevalence of metabolic syndrome and its hepatic involvement in young hyperinsulinaemic overweight patients with polycystic ovarian syndrome 105
Whole blood EBV-DNA predicts outcome in diffuse large B-cell lymphoma 105
Portal vein tumor thrombosis revascularization during sorafenib treatment for hepatocellular carcinoma 103
L'insufficienza epatica: algoritmi diagnostici e trattamenti medici 103
Affective temperaments and psychopathological dimensions of personality in bipolar and cyclothymic patients 103
Relationship between gastric localization of hepatitis C virus and mucosa-associated lymphoid tissue in Helicobacter pylori infection 102
Prevalence, characteristics and severity of non-alcoholic fatty liver disease in patients with chronic plaque psoriasis 102
Prognostic factors for survival in patients with early-intermediate hepatocellular carcinoma undergoing non-surgical therapy: comparison of Okuda, CLIP, and BCLC staging systems in a single Italian centre. 100
Risk factors for intrahepatic recurrence of hepatocellular carcinoma in cirrhotic patients treated by percutaneous ethanol injection 99
Evaluation of the albumin-gamma-glutamyl transferase isoenzyme as a diagnostic marker of hepatocellular carcinoma-complicating liver cirrhosis. 99
Long-term metformin treatment is able to reduce the prevalence of metabolic syndrome and its hepatic involvement in young hyperinsulinaemic overweight patients with polycystic ovarian syndrome 96
Liver transplantation in patients with alcoholic liver disease: A retrospective study 96
Prevalence, characteristics and management of occult hepatitis B virus infection in patients with chronic lymphocytic leukemia: a single center experience 95
Liver transplantation for hepatitis B virus patients: long-term results of three therapeutic approaches 94
Liver involvement in hereditary hemorrhagic telangiectasia: can breath test unmask impaired hepatic first-pass effect? 94
DNA ploidy pattern in human chronic liver diseases and hepatic nodular lesions. Flow cytometric analysis on echo-guided needle liver biopsy 94
Treatment of genotype-1 hepatitis C recurrence after liver transplant improves survival in both sustained responders and relapsers 94
Presence of portal vein thrombosis in liver cirrhosis is strongly associated with low levels of ADAMTS-13: a pilot study 94
TACE with degradable starch microspheres (DSM-TACE) as second-line treatment in HCC patients dismissing or ineligible for sorafenib 94
Severe Skin Burn at Needle Entry Point Complicating Radiofrequency Ablation for Hepatocellular Carcinoma 93
[Natural history, diagnosis and treatment of chronic hepatitis B and C in hemodialysis patients] 93
Doppler ultrasonographic evaluation of blood flow in the superior mesenteric artery in celiac patients and in healthy controls in fasting conditions and after saccharose ingestion 93
Treatment of hepatitis C in compensated cirrhotic patients is equally effective before and after liver transplantation 93
The nonstandard liver, a hidden resource that cannot be overlooked: implications for the identification of the best recipient. 92
Contrast-enhanced gray-scale harmonic ultrasound in the efficacy assessment of ablation treatments for hepatocellular carcinoma 92
Treatment of genotype-1 hepatitis C recurrence after liver transplant improves survival in both sustained responders and relapsers 91
Long-term metformin treatment is able to reduce the prevalence of metabolic syndrome and its hepatic involvement in young hyperinsulinaemic overweight patients with polycystic ovarian syndrome 90
Gastric wall thickness in normal and neoplastic subjects: a prospective study performed by abdominal ultrasound 89
Single Hepatocellular Carcinoma Smaller than 2 cm: Are Ethanol Injection and Radiofrequency Ablation Equally Effective? 89
Lipohyperplasia of the ileocaecal valve as a cause of intestinal haemorrhage: an ultrasound Doppler study 88
Enhancement patterns of intrahepatic mass-forming cholangiocarcinoma at multiphasic computed tomography and magnetic resonance imaging and correlation with clinicopathologic features 87
[Liver transplantation] 85
Botulinum toxin B ultrasound-guided injections for sialorrhea in amyotrophic lateral sclerosis and Parkinson's disease. 84
HepatoCATT Study Group for the Multidisciplinary Management of HCC. Interventional oncology treatments for unresectable early stage HCC in patients with a high risk for intraprocedural bleeding: Is a single-step combined therapy safe and feasible? 83
Contrast-enhanced power doppler of the intestinal wall in the evaluation of patients with Crohn disease 81
Amantadine-induced livedo reticularis occurring during treatment of chronic hepatitis C 81
Combined locoregional treatment of patients with hepatocellular carcinoma: State of the art 81
Sarilumab use in severe SARS-CoV-2 pneumonia 81
Contrast-enhanced ultrasound in the short-term evaluation of hepatocellular carcinoma after locoregional treatment 80
Lung ultrasonography for early management of patients with respiratory symptoms during COVID-19 pandemic 80
Prevalence and predictors of non-alcoholic steatohepatitis in subjects with morbid obesity and with or without type 2 diabetes. 80
Botulinum toxin-B ultrasound-guided injections for sialorrhea in amytrophic lateral sclerosis and Parkinson's disease 79
A case of variant angina in a patient under chronic treatment with sorafenib 79
An update on clinical applications of hepatospecific contrast media in magnetic resonance imaging of liver parenchyma 79
Liver Stiffness in Pediatric Patients with Fatty Liver Disease: Diagnostic Accuracy and Reproducibility of Shear-Wave Elastography 79
HEPATOCATT STUDY GROUP. Critical analysis of major and ancillary features of LI-RADS v2018 in the differentiation of small (≤ 2 cm) hepatocellular carcinoma from dysplastic nodules with gadobenate dimeglumine-enhanced magnetic resonance imaging. 79
Improved gut microbiota features after the resolution of SARS‑CoV‑2 infection 79
Liver transplantation in Italy: preliminary 10-year report. The Monotematica Aisf-Olt Study Group 78
Impact of new DAA therapy on real clinical practice: A multicenter region-wide cohort study 78
Bridging and downstaging treatments for hepatocellular carcinoma in patients on the waiting list for liver transplantation 77
Usefulness of contrast enhanced ultrasound in monitoring therapeutic response after hepatocellular carcinoma treatment 77
Is coeliac disease a confounding factor in the diagnosis of NASH? 76
Real-time contrast-enhanced ultrasound--a new simple tool for detection of peritoneal-pleural communications in hepatic hydrothorax 75
Clinical suspicion of pancreatic neoplasm: does echo-guided fine-needle biopsy modify patient management? 75
Hepatocellular Carcinoma is Associated with Gut Microbiota Profile and Inflammation in Non-Alcoholic Fatty Liver Disease 75
Treatment of genotype-1 hepatitis C recurrence after liver transplant improves survival in both sustained responders and relapsers 74
Long-term maintenance of sustained virological response in liver transplant recipients treated for recurrent hepatitis C 74
Subclinical atherosclerosis is linked to small intestinal bacterial overgrowth via vitamin K2-dependent mechanisms 74
Gallbladder emptying, plasma levels of estradiol and progesterone, and cholecystokinin secretion in liver cirrhosis 73
Portal vein thrombosis occurrence in a cirrhotic patient during treatment with rivaroxaban 72
Skeletal Muscle Loss during Multikinase Inhibitors Therapy: Molecular Pathways, Clinical Implications, and Nutritional Challenges. 72
Contrast ultrasound LI-RADS LR-5 identifies hepatocellular carcinoma in cirrhosis in a multicenter restropective study of 1,006 nodules 72
Characterization of the gut-liver-muscle axis in cirrhotic patients with sarcopenia 72
Correlation Between QElaXto Techniques and Supersonic Imagine for Liver Stiffness Quantification in Chronic Liver Disease 72
Totale 11.110
Categoria #
all - tutte 96.486
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 96.486


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020758 0 0 0 0 0 0 0 101 152 135 194 176
2020/20211.564 98 170 16 149 194 58 156 24 228 92 317 62
2021/20222.119 143 170 38 128 130 55 43 316 76 156 391 473
2022/20234.705 620 587 387 665 298 560 248 400 527 103 191 119
2023/20242.546 117 697 98 123 115 379 140 95 31 160 235 356
2024/20251.948 131 133 476 206 408 199 232 163 0 0 0 0
Totale 19.495